Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.49p
   
  • Change Today:
    -0.21p
  • 52 Week High: 40.00p
  • 52 Week Low: 8.00p
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 248,059
  • Market Cap: £28.83m
  • RiskGrade: 479
  • Beta: 0.01

Futura's topical erection gel recommended for EU approval

By Josh White

Date: Friday 19 Mar 2021

LONDON (ShareCast) - (Sharecast News) - Pharmaceuticals company Futura Medical said on Friday that the relevant EU notified body has completed the review of its technical dossier for 'MED3000', with a recommendation to certificate MED3000 as a class 2B approved medical device.
The AIM-traded firm said once the certificate was received, its MED3000 topical gel formulation would become the first pan-European topical treatment for erectile dysfunction, available without a doctor's prescription.

Once EU certification and the resultant CE-mark is granted, the board said it would be able to seek "rapid approval" in a number of countries around the world, in regions including the Middle East, Africa, the Far East and Latin America, where 'fast-track' review was permitted based on recognition of the CE mark.

The CE marking would also be recognised in the United Kingdom market until 30 June, and in the period leading up to that, the company said it would secure the new post-Brexit UKCA mark.

That would also be a streamlined process, as it was understood the UK application could bridge to the EU approval.

"The recommendation to approve MED3000 in Europe is a huge milestone for Futura in the development of MED3000," said chief executive officer James Barder.

"We look forward with excitement to bringing MED3000 to patients in Europe as the first, clinically proven treatment for erectile dysfunction that is highly differentiated with its rapid speed of onset.

"Once the certificate is issued, MED3000 may be marketed throughout the EU without the need of a doctor's prescription subject to any national marketing restrictions."

At the close on Friday, shares in Futura Medical were up 172.22% at 49p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 9.49p
Change Today -0.21p
% Change -2.16 %
52 Week High 40.00p
52 Week Low 8.00p
Volume 248,059
Shares Issued 303.83m
Market Cap £28.83m
Beta 0.01
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.52% below the market average41.52% below the market average41.52% below the market average41.52% below the market average41.52% below the market average
34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average
Price Trend
94.21% below the market average94.21% below the market average94.21% below the market average94.21% below the market average94.21% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Income Not Available
Growth
23.02% above the market average23.02% above the market average23.02% above the market average23.02% above the market average23.02% above the market average
24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 04-Jun-2025

Time Volume / Share Price
16:24 50,000 @ 9.44p
16:21 21,795 @ 9.44p
15:09 100 @ 9.02p
15:09 28 @ 9.90p
15:09 11 @ 9.02p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page